These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 30216413

  • 21. Molecular pathology of MELAS and L-arginine effects.
    Koga Y, Povalko N, Nishioka J, Katayama K, Yatsuga S, Matsuishi T.
    Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
    [Abstract] [Full Text] [Related]

  • 22. L-arginine improves the symptoms of strokelike episodes in MELAS.
    Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, Fujimoto S, Matsuishi T.
    Neurology; 2005 Feb 22; 64(4):710-2. PubMed ID: 15728297
    [Abstract] [Full Text] [Related]

  • 23. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.
    El-Hattab AW, Emrick LT, Chanprasert S, Craigen WJ, Scaglia F.
    Int J Biochem Cell Biol; 2014 Mar 22; 48():85-91. PubMed ID: 24412347
    [Abstract] [Full Text] [Related]

  • 24. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.
    Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T.
    Ann N Y Acad Sci; 2010 Jul 22; 1201():104-10. PubMed ID: 20649546
    [Abstract] [Full Text] [Related]

  • 25. MELAS syndrome: an acute stroke-like episode complicated by renal tubular acidosis.
    Ni Cathain D, Browne E, Skehan K, Boyle K.
    BMJ Case Rep; 2021 Nov 02; 14(11):. PubMed ID: 34728512
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. MELAS: A Complex and Challenging Diagnosis.
    Khandwala K, Ahmed A, Sheikh T.
    J Coll Physicians Surg Pak; 2018 Mar 02; 28(3):S46-S48. PubMed ID: 29482705
    [Abstract] [Full Text] [Related]

  • 30. Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.
    Guerrero-Molina MP, Bernabeu-Sanz Á, Ramos-González A, Morales-Conejo M, Delmiro A, Domínguez-González C, Arenas J, Martín MA, González de la Aleja J.
    Neuroradiology; 2024 Mar 02; 66(3):389-398. PubMed ID: 38114794
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. MELAS and L-arginine therapy.
    Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Katayama K, Matsuishi T.
    Mitochondrion; 2007 Mar 02; 7(1-2):133-9. PubMed ID: 17276739
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.
    Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL.
    Neurology; 1993 Dec 02; 43(12):2484-90. PubMed ID: 8255444
    [Abstract] [Full Text] [Related]

  • 37. Correlation of basal ganglia magnetic resonance spectroscopy with Apgar score in perinatal asphyxia.
    Pavlakis SG, Kingsley PB, Harper R, Buckwald S, Spinazzola R, Frank Y, Prohovnik I.
    Arch Neurol; 1999 Dec 02; 56(12):1476-81. PubMed ID: 10593302
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.